Drug Profile
Research programme: antidepressants - Johnson & Johnson
Alternative Names: Dual mechanism antidepressants - Johnson & Johnson; serotonin7 receptor antagonists - Johnson & JohnsonLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Johnson & Johnson
- Class Isoxazoles
- Mechanism of Action Alpha 2 adrenergic receptor antagonists; Serotonin 7 receptor antagonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Major depressive disorder in Spain
- 16 Jul 2016 No recent reports of development identified for preclinical development in Major depressive disorder in USA
- 13 Sep 2004 Preclinical trials in Depression in Spain (unspecified route)